Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have generated the first known disease-specific induced pluripotent stem cell (iPSC) lines from a patient with familial transthyretin amyloidosis (ATTR). The findings, which are reported in Stem Cell…
Source:Researchers model familial amyloidosis in vitro using iPSC technology
Thursday, October 31, 2013
Researchers model familial amyloidosis in vitro using iPSC technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment